Evins, A. Eden, MD, MPH

Director, Center for Addiction Medicine, Massachusetts General Hospital
William Cox Family Associate Professor of Psychiatry in the Field of Addiction Medicine, Harvard Medical School


Dr. Evins is Director of the Center for Addiction Medicine and an AttendingPsychiatrist in the Schizophrenia and Depression Clinical and Research Programsat the Massachusetts General Hospital. She is Associate Professor of Psychiatry at Harvard Medical School. Dr. Evins earned her undergraduatedegree at the University of Virginia in Charlottesville, VA, and her medicaldegree at the Medical University of South Carolina in Charleston. She completedher residency in adult psychiatry at the Massachusetts Mental Health Center andLongwood Psychiatry Residency Training Program in Boston, where she was alsoChief Resident. She conducted a fellowship in molecular biology at the MailmanResearch Center of McLean Hospital and a second fellowship in schizophrenia researchat the Massachusetts General Hospital with Dr. Donald Goff. She earned aMasters in Public Health in Clinical Effectiveness at the Harvard School ofPublic Health in 2005. Her research interests include pharmacotherapy for dualdisorders of major mental illness and addiction, biological basis forresponsiveness to reward and for craving, negative symptoms in schizophrenia,treatment for cognitive dysfunction in schizophrenia. She is an expert intreatment of nicotine dependence in patients with schizophrenia and depression.She has authored book chapters, reviews, and articles that have been publishedin scientific journals, such as American Journal of Psychiatry, BiologicalPsychiatry, Neuropsychopharmacology, Journal of Clinical Psychiatry, Journal ofClinical Psychopharmacology, and Psychopharmacology.

Dr. Evins has been the recipient of a career development award from theNational Institutes of Drug Abuse (NIDA), the Massachusetts Department ofPublic Health Tobacco Control Program Young Investigator Award, the NIMH NewClinical Drug Evaluation Unit Young Investigator Award, and has twice been therecipient of the National Alliance for Research on Schizophrenia and Depression(NARSAD) Young Investigator Award. Dr. Evins is currently PI on two R01 grants,an R21 grant and is Project Director and co-PI on a U01 grant from NIDA tostudy novel treatments for smoking cessation and prevention of relapse tosmoking and to develop translational surrogate markers for response. She iscurrently a mentor on three NARSAD Young Investigator Awards.